BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28193546)

  • 1. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.
    Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL
    Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.
    Abais JM; Xia M; Li G; Gehr TW; Boini KM; Li PL
    Free Radic Biol Med; 2014 Feb; 67():211-20. PubMed ID: 24140862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
    Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
    J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
    Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
    J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
    Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
    J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.
    Zhang C; Boini KM; Xia M; Abais JM; Li X; Liu Q; Li PL
    Hypertension; 2012 Jul; 60(1):154-62. PubMed ID: 22647887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.
    Xia M; Conley SM; Li G; Li PL; Boini KM
    Cell Physiol Biochem; 2014; 34(3):829-41. PubMed ID: 25171193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia.
    Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL
    Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats.
    Yi F; Xia M; Li N; Zhang C; Tang L; Li PL
    Hypertension; 2009 Jan; 53(1):90-6. PubMed ID: 19029489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2.
    Yi F; Chen QZ; Jin S; Li PL
    Cell Physiol Biochem; 2007; 20(6):909-18. PubMed ID: 17982273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.
    Zhang C; Xia M; Boini KM; Li CX; Abais JM; Li XX; Laperle LA; Li PL
    Pflugers Arch; 2011 Sep; 462(3):455-67. PubMed ID: 21647593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia.
    Huang D; Li G; Zhang Q; Bhat OM; Zou Y; Ritter JK; Li PL
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166146. PubMed ID: 33862145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene.
    Boini KM; Xia M; Koka S; Gehr TW; Li PL
    Oncotarget; 2016 Apr; 7(14):19031-44. PubMed ID: 26980705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome Biogenesis and Lysosome Function Determine Podocyte Exosome Release and Glomerular Inflammatory Response during Hyperhomocysteinemia.
    Huang D; Li G; Bhat OM; Zou Y; Li N; Ritter JK; Li PL
    Am J Pathol; 2022 Jan; 192(1):43-55. PubMed ID: 34717894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin.
    Koka S; Xia M; Zhang C; Zhang Y; Li PL; Boini KM
    Cell Physiol Biochem; 2019; 53(2):355-365. PubMed ID: 31385664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
    Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.
    Li C; Xia M; Abais JM; Liu X; Li N; Boini KM; Li PL
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):551-61. PubMed ID: 23529346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.